drugset / Trial / NCT06367218

Opioid-Free Combined Anesthesia With Spontaneous Breathing for VATS

NCT06367218

Recruiting 480 enrolled Tongji Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

Non-tracheal intubated combined anesthesia with preserved spontaneous breathing significantly enhances the quality and speed of recovery post-VATS for patients undergoing lung nodule surgery. The "opioid-sparing strategy," which substitutes ketamine for opioids during surgery, not only provides effective analgesia but also protects perioperative lung function and reasonably prevents the occurrence of opioid-related adverse reactions; it also reduces medical costs and shortens the average hospital stay. However, the degree of benefit to patients lacks high-level clinical evidence. This study aims to comprehensively assess the effect of opioid-free combined anesthesia with preserved spontaneous breathing for VATS lung nodule surgery on postoperative rapid recovery from multiple aspects including postoperative lung function and pulmonary complications, pain, gastrointestinal function, nausea/vomiting, cognitive function, and depression/anxiety, intending to expand the dataset and application prospects in this field, and increase feasibility experience.

Timeline

Start
2024-10-01
Primary completion
2026-07-01
Completion
2026-08-01

Drugs

EvaluationDrugModalityDoseRoute
Background Esketamine Other / unclassified 0.5 mg/kg Intravenous
Background Remifentanil Small molecule 0.01 ug/kg Intravenous
Background Remifentanil Small molecule 0.1 ug/kg Intravenous
Background Sufentanil Other / unclassified 0.1 ug/kg Intravenous
Background Sufentanil Other / unclassified 0.5 ug/kg Intravenous

Indications

No indication recorded.